Mathes Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Mathes Company, Inc.
- $283 Million
- Q3 2024
A detailed history of Mathes Company, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Mathes Company, Inc. holds 9,115 shares of XBI stock, worth $862,187. This represents 0.32% of its overall portfolio holdings.
Number of Shares
9,115
Previous 9,440
3.44%
Holding current value
$862,187
Previous $875,000
2.97%
% of portfolio
0.32%
Previous 0.32%
Shares
13 transactions
Others Institutions Holding XBI
# of Institutions
927Shares Held
101MCall Options Held
28.4MPut Options Held
33.4M-
Goldman Sachs Group Inc New York, NY12.7MShares$1.21 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY12.3MShares$1.16 Billion0.1% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$873 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$759 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$733 Million0.45% of portfolio